20077 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
NOVEL FORMULATION OF DICLOFENAC
#602SUSTAINED RELEASE INJECTABLE NEUROSTEROID FORMULATIONS
#603FOOD INDEPENDENT IMMEDIATE RELEASE DRUG FORMULATION WITH ABUSE DETERRENCE AND OVERDOSE PROTECTION
#604Chewing gum comprising nicotine
#605Polyphenol-containing solid composition
#606Nanoparticles, composition and system for delivering 5FU and uses thereof
#607STABLE PROTEIN COMPOSITIONS
#608Highly concentrated powdered oleoresin composition and process for preparation thereof
#609Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
#610SOLID DISPERSIONS OF COMPOUNDS USING POLYVINYL ALCOHOL AS A CARRIER POLYMER
#611Dietary supplement derived from natural prodcuts by hot melt extrusion (HME) processing
#612Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir
#613DRY POWDERS OF CANNABINOIDS AND METHODS FOR PREPARING DRY POWDERS
#614Sustained Release Cannabinoid Formulations
#615Sustained release olanzapine formulations
#616Multi-component nanoconstructs
#617SUSTAINED DRUG-RELEASE CONTACT LENS
#618Multivitamin extrudates
#619COMPOSITIONS AND METHODS RELATED TO SCAVENGER PARTICLES
#620Novel formulation of metaxalone
#621Reduction of flake-like aggregation in nanoparticulate active agent compositions
#622Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof
#623Production of encapsulated nanoparticles at high volume fractions
#624Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereof
#625Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications
#626SALIPRO PARTICLES
#627METHOD OF PREPARING NANOPARTICULATE TOPICAL COMPOSITION
#628FIXED-DOSE COMBINATIONS OF ANTIVIRAL COMPOUNDS
#629Nanoparticulate Meloxicam Formulations
#630Nanoparticulate meloxicam formulations
#631USE OF WATER-SOLUBLE POLYMERS BASED ON N-VINYLPYRROLIDONE AND ACRYLIC ACID AS PHARMACEUTICAL ADJUVANTS
#632Anti-malaria compositions and methods
#633Stable dry probiotic compositions for special dietary uses
#634PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN
#635COMPOSITION COMPRISING SATIETY-INDUCING PARTICLES
#636Process for preparing poly(glycolide-co-lactide) copolymer microparticles
#637Controlled release dosage form
#638Controlled release dosage form
#639Solid dispersions of Coenzyme Q
#640DECOY NANOPARTICLES TO DISRUPT CANCER CELL-STROMAL CELL NETWORKS
#641Method of inducing satiety
#642CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT
#643ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#644Oral pharmaceutical dosage form for the delivery of a peptide and/or protein
#645Pharmaceutical composition containing Celecoxib
#646Compositions comprising water dispersible nanoparticles of a retinoid compound
#647FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR
#648Methods and devices for treating a retinal detachment
#649Formulation Obtained from a Powder Mixture Comprising an Inorganic Pigment
#650Bendamustine Solid Dispersions And Continuous Infusion
#651PROTECTIVE COMPOSITION FOR GASTROINTESTINAL MUCOSA
#652PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#653Method for improving the dissolution profile of a biologically active material
#654METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES
#655Controlled release system for pulmonary delivery of surfactant protein D
#656Prostamide-containing intraocular implant
#657Hydrogel compositions
#658Preparations containing amorphous emodepside
#659Oil-in-water method for making polymeric implants containing a hypotensive lipid
#660Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#661Methods of making and using polyphenols complexed with a protein, peptide, amino acid, polysaccaride, disaccharide, or monosaccharide
#662PHARMACEUTICAL POWDER COMPOSITION AND ITS USE IN THE CONTROL OF POST-PRANDIAL GLYCAEMIC PROFILE
#663Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein
#664Apparatus for a mass production of monodisperse biodegradable polymer-based microspheres and a multi-channel forming device incorporatable therein
#665CHEMOEMBOLISATION
#666Therapeutic compounds and uses thereof
#667SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion
#668Degradable Microparticles for Protein and Small Molecule Delivery
#669NOVEL ESTERIFIED CELLULOSE ETHERS OF VERY HIGH MOLECULAR WEIGHT
#670TESTOSTERONE UNDECANOATE COMPOSITIONS
#671Formulation of indomethacin
#672TREATING FUNGAL INFECTION OF THE NAIL UNIT
#673Reactive and sorbent materials
#674Pharmaceutical compositions comprising lonafarnib and ritonavir
#675METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#676Therapeutic compounds and uses thereof
#677Low-substituted hydroxypropyl cellulose, production method thereof, and solid preparation
#678Low-substituted hydroxypropyl cellulose, production method thereof, and solid preparation
#679SCALABLE MICROPARTICULATE FORMULATIONS CONTAINING POLYMORPHIC NIMODIPINE FORM 2 PREPARED BY A SOLVENT EVAPORATION PROCESS
#680Hydroxyalkyl alkyl cellulose, method for producing the same, and solid preparation
#681PEDIATRIC FORMULATION
#682Bottlebrush copolymers and uses thereof
#683Ophthalmic drug sustained release formulation and uses thereof
#684CYCLODEXTRIN COMPOUNDS FOR THE PREVENTION AND TREATMENT OF AGING
#685Sequentially decomposable polypeptide-based nanocarriers with protective shell and preparation thereof
#686Gelling esterified cellulose ethers
#687CORE-SHELL PARTICLES FOR CONTROLLED RELEASE
#688Methods for treating cryptosporidiosis using triazolopyridazines
#689Biodegradable polymer formulations for extended efficacy of botulinum toxin
#690Stabilized polymeric carriers for therapeutic agent delivery
#691Alternating and semi-alternating poly(ester-anhydride) copolymers
#692High density peptide polymers
#693Pharmaceutical compositions
#694Solid dispersions
#695Suspension containing nano-cocrystal and manufacturing method
#696Nanoparticulate composition
#697Sustained release particle formulations
#698Formulations of a Bruton's tyrosine kinase inhibitor
#699Microcapsules comprising lutein or lutein ester
#700Crystalline forms of therapeutic compounds and uses thereof
#701METHODS AND COMPOSITIONS OF SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
#702Novel formulation of metaxalone
#703Nanoparticulate compositions and formulations of piperazine compounds
#704Cyclodextrin Compositions Encapsulating a Selective ATP Inhibitor and Uses Thereof
#705Nasal powder formulation for treatment of hypoglycemia
#706Gold Particle for Use in Therapy to Prevent Scar Formation
#707Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#708INJECTABLE AGGREGATES FOR JOINT AND SOFT TISSUE DISTRESS
#709METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO
#710Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereof
#711Combination formulation of three antiviral compounds
#712Anticancer compositions
#713Solid dispersion of decoquinate, a preparation process and its application
#714MULTI-PHASE RELEASE OF SPORTS NUTRITION AND ENERGY DRINK COMPOSITIONS UTILIZING LIPID PARTICULATES
#715Solid dispersions of low-water solubility actives
#716Long acting pharmaceutical composition of protease inhibitor
#717Pharmaceutical compositions for treating acne
#718Controlled release dosage form
#719Controlled release dosage form with enhanced pharmacokinetics
#720TREATING FUNGAL INFECTION OF THE NAIL UNIT
#721Method for producing organic material microparticles, and method for modifying organic material microparticles
#722FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#723Amorphous Vortioxetine Hydrobromide
#724IMPROVED FORMULATIONS OF VEMURAFENIB AND METHODS OF MAKING THE SAME
#725Mass production and size control of nanoparticles through controlled microvortices
#726Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#727-based composition for use as an anti-AIDS drug
#728Production of encapsulated nanoparticles at high volume fractions
#729COMBINATION FOR THE TREATMENT OF CONDITIONS INVOLVING MUSCULAR PAIN
#730Composition based on COQ10
#731In vivo stealth nanoparticle
#732Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs
#733TYROSINE KINASE INHIBITOR FORMULATIONS FOR THE TREATMENT OF MAST CELL-MEDIATED INFLAMMATORY DISEASES AND METHODS OF USE THEREOF
#734PHARMACEUTICAL PREPARATION AND METHOD OF ITS PRODUCTION AND USE
#735Amorphous form of lomitapide mesylate
#736Pharmaceutical combination composition comprising complex formulations of Ivacaftor and Lumacaftor and their salts and derivatives, process for their preparation thereof and pharmaceutical compositions containing them
#737Nanoparticle isoflavone compositions and methods of making and using the same
#738MANUFACTURE OF A PHARMACEUTICAL PRODUCT
#739Compositions and methods for increasing the bioavailability of one or more compounds
#740Formulations of deferasirox and methods of making the same
#741NATURAL, BIODEGRADABLE BEADLETS AND PROCESS TO MANUFACTURE
#742Pharmaceutical formulation of palbociclib and a preparation method thereof
#743SOLID MOLECULAR DISPERSION OF FESOTERODINE HYDROGEN FUMARATE AND POLYMERIC BINDER
#744Hydrogel compositions
#745Method for producing solid dispersion containing hardly soluble polyphenol
#746COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#747Implantable therapeutic delivery system and methods thereof
#748Injectable neurosteroid formulations containing nanoparticles
#749Formulations of viloxazine
#750Pharmaceutical Compositions For Poorly Water-Soluble Compounds
#751Iron Chelators and Use Thereof for Reducing Transplant Failure During Rejection Episodes
#752Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase
#753ACTIVE-LOADED PARTICULATE MATERIALS FOR TOPICAL ADMINISTRATION
#754Esterified cellulose ethers of low acetone-insoluble content
#755Compositions of multiple aripiprazole prodrugs
#756Therapeutic nanoparticles having EGFR ligands and methods of making and using same
#757PROGRAMMABLE LIQUID, GEL AND BIOHYBRID COMPARTMENTS AND METHODS OF USE
#758A Method of Preparing Amorphous Solid Dispersion in Submicron Range by Co-Precipitation
#759SEMI-SOLID CHEWABLE DOSAGE FORM FOR OVER-THE-COUNTER MEDICATIONS AND METHOD FOR PRODUCING SAME
#760Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#761Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#762Method for conducing concentrated oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized oil
#763Lyophilized compositions comprising albumin-rankl or albumin-GD2 paclitaxel nanoparticle complexes
#764Methods of using albumin-antibody nanoparticle complex compositions for treating cancer
#765Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating cancer
#766Lyophilized compositions comprising albumin-antibody paclitaxel nanoparticle complexes
#767Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same
#768Lyophilized compositions comprosing albumin-EGFR paclitaxel nanoparticle complexes
#769Albumin-CTLA-4 paclitaxel nanopartilce complex compositions and methods of making and using the same
#770Methods of making lyophilized compositions comprising albumin-VEGF paclitaxel nanoparticle complexes
#771PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE
#772COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES
#773Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
#774Immune-modifying nanoparticles for the treatment of inflammatory diseases
#775Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation
#776Nanoparticulate meloxicam formulations
#777ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF
#778Pharmaceutical composition containing docetaxel
#779Taste-masked oral pharmaceutical composition
#780FUNCTIONALIZED NANOPARTICLES WITH ENCAPSULATED CARGO AND METHOD OF THEIR SELF-ASSEMBLY
#781Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds
#782Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
#783Amine cationic lipids and uses thereof
#784Pharmaceutical composition and use
#785ALLISARTAN ISOPROXIL SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION
#786NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#787Stabilized HME composition with small drug particles
#788Polymeric particles, method for cytosolic delivery of cargo, methods of making the particles
#789Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same
#790Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof
#791Solid dispersions of insoluble drug and preparation method thereof
#792OLAPARIB CO-PRECIPITATE AND PREPARATION METHOD THEREOF
#793Mixture of lafesih magnetic nanoparticles with different curie temperatures for improved inductive heating efficiency for hyperthermia therapy
#794Carrier-antibody compositions and methods of making and using the same
#795Solid composition comprising amorphous sofosbuvir
#796Pharmaceutical composition and administrations thereof
#797Formulation of indomethacin
#798Composition for dust particle reduction
#799Chitin-glucan complex, its preparation, and uses
#800Compositions and methods for modified dendrimer nanoparticle delivery
#801Solid dispersion
#802Carrier-antibody compositions and methods of making and using the same
#803Methods for fabrication of epinephrine bitartrate nanoparticles and epinephrine bitartrate nanoparticles fabricated thereby
#804NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#805Bosutinib forms and preparation methods thereof
#806PHARMACEUTICAL COMPOSITION
#807Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#808Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds
#809ACTIVE INGREDIENT (I) CONTAINING COMPOSITION AND METHOD FOR PREPARING SAME
#810Bioerodible silicon-based compositions for delivery of therapeutic agents
#811Treatment of hepatitis delta virus infection
#812DELIVERY OF BIOLOGIC THERAPEUTICS
#813Aprepitant oral liquid formulations
#814Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity
#815Formulations of deferasirox and methods of making the same
#816Carrier-antibody compositions and methods of making and using the same
#817Carrier-antibody compositions and methods of making and using the same
#818Compositions and methods for nanoparticle lyophile forms
#819Pharmaceutical compositions of therapeutically active compounds
#820Method of making metal based cationic surfactant nano particles and their use
#821Chewable composition
#822Diether based biodegradable cationic lipids for siRNA delivery
#823Pharmaceutical composition with improved bioavailability
#824Nanoparticle isoflavone compositions and methods of making and using the same
#825Functional Nanoparticle Composite Comprising Chitosan
#826Polymer compositions in biomedical applications
#827Cancer cell targeting using nanoparticles
#828Nanoencapsulation of hydrophilic active compounds
#829Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#830Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
#831Esterified cellulose ethers of high molecular weight and homogeneity
#832Synthetic Platelets
#833Solid dispersions of insoluble drug and preparation method thereof
#834Methods for superdisintegrant-based composite particles for dispersion and dissolution of active pharmaceutical agents
#835DUAL RESPONSIVE BRAIN TARGETED NANOPARTICLES AND THEIR APPLICATIONS
#836Carrier-antibody compositions and methods of making and using the same
#837TRANSMUCOSAL AND TRANSEPITHELIAL DRUG DELIVERY SYSTEM
#838Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#839Poly(vinyl benzoate) nanoparticles for molecular delivery
#840Carrier-antibody compositions and methods of making and using the same
#841Augmentation of oncology immunotherapies by pterostilbene containing compositions
#842Oral rapamycin nanoparticle preparations and use
#843Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#844PARTICLES CONTAINING PHOSPHOLIPIDS OR BIOACTIVE FATTY ACIDS AND USES THEREOF
#845Dialkyl sulfosuccinate compositions, method of making, and method of use
#846MEDIA MILLING PROCESS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN PROPELLANTS
#847Microparticles and nanoparticles having negative surface charges
#848Bendamustine solid dispersions and continuous infusion
#849NANOPARTICLE DELIVERY SYSTEMS FOR CYTOLYTIC PEPTIDE PRODRUGS
#850Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#851Cellulose ethers esterified with dicarboxylic acid
#852Porous microparticles with high loading efficiencies
#853Formulations of viloxazine
#854Pharmaceutical preparation and method of its production and use
#855NANOPARTICLE-CONTAINING HYDROGELS
#856Formulation of sparingly soluble compounds by hot-melt extrusion
#857Preparation of a powdery pharmaceutical composition by means of cryo-milling
#858Functional, cross-linked nanostructures for tandem optical imaging and therapy
#859Formulations of viloxazine
#860Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof
#861PROCESS FOR PRODUCING CELLULOSE DERIVATIVES OF HIGH BULK DENSITY AND GOOD FLOWABILITY
#862METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#863Thermo-kinetic mixing for pharmaceutical applications
#864Solid Pharmaceutical Compositions Containing Pregabalin
#865Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#866Ferroporphyrin solid dispersion and preparation method thereof
#867Controlled release dosage form
#868Controlled release dosage form
#869Method for treating itch
#870Reduction of flake-like aggregation in nanoparticulate active agent compositions
#871Reduction of flake-like aggregation in nanoparticulate active agent compositions
#872INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
#873PURIFIED CBD AND CBDA, AND METHODS, COMPOSITIONS AND PRODUCTS EMPLOYING CBD OR CBDA
#874Reduction of flake-like aggregation in nanoparticulate active agent compositions
#875Crystalline maltitol powder less prone to consolidation and method for production thereof
#876Magnesium bath salt
#877Ophthalmic suspension composition
#878Prostamide-containing intraocular implant
#879Hydrogel compositions
#880Carrier-antibody compositions and methods of making and using the same
#881Carrier-antibody compositions and methods of making and using the same
#882Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
#883Polymer, and pharmaceutical composition employing the same
#884Iron chelators and use thereof for reducing transplant failure during rejection episodes
#885Carrier-antibody compositions and methods of making and using the same
#886Extruded chewable formulation comprising bound water
#887Nanoparticle isoflavone compositions and methods of making and using the same
#888Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nanoparticle composition
#889PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES PHENYLEPHRINE RESINATE PARTICLES AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS
#890MESOPOROUS ALUM NANOPARTICLES AS A UNIVERSAL PLATFORM FOR ANTIGEN ADSORPTION, PRESENTATION, AND DELIVERY
#891Synergistic enhancement of the delivery of nucleic acids via blended formulations
#892Hydrophilic Microparticles, Drug-Delivery Material, Method For Manufacturing Thereof And Methods For Delivery of A Drug-Delivery Composition
#893Micro-needle and micro-needle patch
#894Use of instant asparagus powder in food, medicine and health food
#895COMPOSITIONS, METHODS, AND SYSTEMS RELATING TO CONTROLLED CRYSTALLIZATION AND/OR NUCLEATION OF MOLECULAR SPECIES
#896Orally disintegrating tablet formulation for enhanced bioavailability
#897Crystalline forms of therapeutic compounds and uses thereof
#898DARUNAVIR FORMULATIONS
#899Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#900Collagen powder, composition and use